These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 27793437)
1. Familial amyloidosis with polyneuropathy type 1 caused by transthyretin mutation Val50Met (Val30Met): 4 cases in a non-endemic area. Andrés N; Poza JJ; Martí Massó JF Neurologia (Engl Ed); 2018; 33(9):583-589. PubMed ID: 27793437 [TBL] [Abstract][Full Text] [Related]
2. Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland - genetic and clinical presentation. Lipowska M; Drac H; Rowczenio D; Gilbertson J; Hawkins PN; Lasek-Bal A; Szewczuk J; Grzybowski J; Gawor M; Stępień-Wojno M; Franaszczyk M; Brydak-Godowska J; Śmierciak R; Ptasińska-Perkowska A; Chandoga J; Petrovic R; Kostera-Pruszczyk A Neurol Neurochir Pol; 2020; 54(6):552-560. PubMed ID: 33373035 [TBL] [Abstract][Full Text] [Related]
3. Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history. Rudolph T; Kurz MW; Farbu E Clin Med Res; 2008 Sep; 6(2):80-2. PubMed ID: 18606975 [TBL] [Abstract][Full Text] [Related]
4. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Ikeda S; Nakazato M; Ando Y; Sobue G Neurology; 2002 Apr; 58(7):1001-7. PubMed ID: 11940682 [TBL] [Abstract][Full Text] [Related]
5. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan. Miyake Z; Nakamagoe K; Ezawa N; Yoshinaga T; Hashimoto R; Sato T; Sekijima Y; Tamaoka A Intern Med; 2019 Mar; 58(5):713-718. PubMed ID: 30333406 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area. Takahashi R; Ono K; Shibata S; Nakamura K; Komatsu J; Ikeda Y; Ikeda T; Samuraki M; Sakai K; Iwasa K; Kayano D; Yamada M J Neurol Sci; 2014 Oct; 345(1-2):231-5. PubMed ID: 25060417 [TBL] [Abstract][Full Text] [Related]
7. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy. Hattori T; Takei Y; Koyama J; Nakazato M; Ikeda S Amyloid; 2003 Dec; 10(4):229-39. PubMed ID: 14986482 [TBL] [Abstract][Full Text] [Related]
8. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey. Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058 [TBL] [Abstract][Full Text] [Related]
9. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy. Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674 [TBL] [Abstract][Full Text] [Related]
10. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan. Ueda M; Yamashita T; Misumi Y; Masuda T; Ando Y Amyloid; 2018 Sep; 25(3):143-147. PubMed ID: 30486687 [TBL] [Abstract][Full Text] [Related]
11. Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy. Tojo K; Tsuchiya-Suzuki A; Sekijima Y; Morita H; Sumita N; Ikeda S Amyloid; 2010 Mar; 17(1):32-5. PubMed ID: 20132088 [TBL] [Abstract][Full Text] [Related]
13. Three Turkish families with different transthyretin mutations. Bekircan-Kurt CE; Güneş N; Yılmaz A; Erdem-Özdamar S; Tan E Neuromuscul Disord; 2015 Sep; 25(9):686-92. PubMed ID: 26115788 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus. Kato-Motozaki Y; Ono K; Shima K; Morinaga A; Machiya T; Nozaki I; Shibata-Hamaguchi A; Furukawa Y; Yanase D; Ishida C; Sakajiri K; Yamada M J Neurol Sci; 2008 Jul; 270(1-2):133-40. PubMed ID: 18410945 [TBL] [Abstract][Full Text] [Related]
15. [Presentations of transthyretin associated familial amyloid polyneuropathy in Argentina]. Chaves M; Bettini M; Marciano S; Sáez S; Cristiano E; Rugiero M Medicina (B Aires); 2016; 76(2):105-8. PubMed ID: 27135849 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis. Koike H; Hashimoto R; Tomita M; Kawagashira Y; Iijima M; Tanaka F; Sobue G Amyloid; 2011 Jun; 18(2):53-62. PubMed ID: 21463231 [TBL] [Abstract][Full Text] [Related]
17. [Late-onset hereditary transthyretin amyloidosis with polyneuropathy. Report of one case]. Matamala JM; Peña C; Moreno-Roco J; Álvarez J; Villegas P; Stuardo A; Puga B; Valjalo R; Correa G; Jeraldo C; Méndez G; Larrondo J; Gosch M; Carrasco R Rev Med Chil; 2022 Sep; 150(9):1260-1265. PubMed ID: 37358138 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm. Sekijima Y; Ueda M; Koike H; Misawa S; Ishii T; Ando Y Orphanet J Rare Dis; 2018 Jan; 13(1):6. PubMed ID: 29343286 [TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation. Murakami T; Nishimura H; Nagai T; Hemmi S; Kutoku Y; Ohsawa Y; Sunada Y J Neurol Sci; 2017 Oct; 381():55-58. PubMed ID: 28991715 [TBL] [Abstract][Full Text] [Related]
20. Clinical and genetic findings in eight Israeli patients with transthyretin-associated familial amyloid polyneuropathy. Leibou L; Frand J; Sadeh M; Lossos A; Kremer E; Livneh A; Yarnitsky D; Herman O; Dabby R Isr Med Assoc J; 2012 Nov; 14(11):662-5. PubMed ID: 23240369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]